【结 构 式】 |
【分子编号】57643 【品名】tert-butyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate 【CA登记号】 |
【 分 子 式 】C11H22N2O2 【 分 子 量 】214.30796 【元素组成】C 61.65% H 10.35% N 13.07% O 14.93% |
合成路线1
该中间体在本合成路线中的序号:(VIII)Coupling between ethyl 3-aminopropionate (I) and N-Boc-glycine (II) by means of EDC and HOBt affords the protected dipeptide (III). After acidic Boc group cleavage in (III), the N-deprotected dipeptide (IV) is acylated by 3,3,3-triphenylpropionic acid (V) to produce amide (VI). Saponification of the ethyl ester group of (VI) yields acid (VII). This is coupled with (R)-1-Boc-3-(aminomethyl)piperidine (VIII) to afford amide (IX), which is further subjected to acidic N-Boc group cleavage. The resultant piperidine derivative (X) is then reductively condensed with cyclohexanecarboxaldehyde (XI) in the presence of NaBH(OAc)3 to furnish the title compound.
【1】 Kimura, T.; Noguchi, K.; Otake, N.; Uchiyama, M.; Naya, A.; Sagara, Y.; Numazawa, T.; Fujikawa, T. (Banyu Pharmaceutical Co., Ltd.); Novel amide derivs.. EP 1213281; WO 0107406 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17639 | beta-Alanine, ethyl ester; ethyl 3-aminopropanoate | 924-73-2 | C5H11NO2 | 详情 | 详情 |
(II) | 18066 | N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid | 4530-20-5 | C7H13NO4 | 详情 | 详情 |
(III) | 57638 | ethyl 3-({2-[(tert-butoxycarbonyl)amino]acetyl}amino)propanoate | C12H22N2O5 | 详情 | 详情 | |
(IV) | 57639 | ethyl 3-[(2-aminoacetyl)amino]propanoate | C7H14N2O3 | 详情 | 详情 | |
(V) | 57640 | 3,3,3-Triphenylpropionic acid; Tritylacetic acid | 900-91-4 | C21H18O2 | 详情 | 详情 |
(VI) | 57641 | ethyl 3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoate | C28H30N2O4 | 详情 | 详情 | |
(VII) | 57642 | N-{2-[(3,3,3-triphenylpropanoyl)amino]acetyl}-beta-alanine | C26H26N2O4 | 详情 | 详情 | |
(VIII) | 57643 | tert-butyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate | C11H22N2O2 | 详情 | 详情 | |
(IX) | 57644 | tert-butyl (3R)-3-({[3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoyl]amino}methyl)-1-piperidinecarboxylate | C37H46N4O5 | 详情 | 详情 | |
(X) | 57645 | N-{2-oxo-2-[(3-oxo-3-{[(3S)piperidinylmethyl]amino}propyl)amino]ethyl}-3,3,3-triphenylpropanamide | C32H38N4O3 | 详情 | 详情 | |
(XI) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)Coupling of acid (IX) with (R)-3-(aminomethyl)-1-Boc-piperidine (X) gives the triamide (XI). Deprotection of both N-Boc and O-t-butyl groups of (XI) with trifluoroacetic acid affords (XII). Finally, reductive alkylation of piperidine (XII) with propionaldehyde in the presence of NaBH3CN/ZnCl2 provides the target compound.
【1】 Sagara, Y.; Kimura, T.; Fujikawa, T.; Noguchi, K.; Ohtake, N.; Identification of novel muscarinic M3 selective antagonists with a conformationally restricted Hyp-Pro spacer. Bioorg Med Chem Lett 2003, 13, 1, 57. |
【2】 Kimura, T.; Noguchi, K.; Otake, N.; Uchiyama, M.; Naya, A.; Sagara, Y.; Numazawa, T.; Fujikawa, T. (Banyu Pharmaceutical Co., Ltd.); Novel amide derivs.. EP 1213281; WO 0107406 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IX) | 62803 | (2R)-1-{[(2S,4R)-4-(tert-butoxy)-1-(3,3,3-triphenylpropanoyl)pyrrolidinyl]carbonyl}-2-pyrrolidinecarboxylic acid | C35H40N2O5 | 详情 | 详情 | |
(X) | 57643 | tert-butyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate | C11H22N2O2 | 详情 | 详情 | |
(XI) | 62804 | tert-butyl (3R)-3-({[((2R)-1-{[(2S,4R)-4-(tert-butoxy)-1-(3,3,3-triphenylpropanoyl)pyrrolidinyl]carbonyl}pyrrolidinyl)carbonyl]amino}methyl)-1-piperidinecarboxylate | C46H60N4O6 | 详情 | 详情 | |
(XII) | 62805 | (2R)-1-{[(2S,4R)-4-hydroxy-1-(3,3,3-triphenylpropanoyl)pyrrolidinyl]carbonyl}-N-[(3S)piperidinylmethyl]-2-pyrrolidinecarboxamide | C37H44N4O4 | 详情 | 详情 |